Modified 2016 American College of Rheumatology Fibromyalgia Criteria, the Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks–American Pain Society Pain Taxonomy, and the Prevalence of Fibromyalgia
Objective To study the prevalence of fibromyalgia (FM) in the general population according to a 2016 modification of the American College of Rheumatology criteria (FM 2016) and the Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks–American Pain S...
Uložené v:
| Vydané v: | Arthritis care & research (2010) Ročník 73; číslo 5; s. 617 - 625 |
|---|---|
| Hlavní autori: | , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
Wiley Subscription Services, Inc
01.05.2021
|
| Predmet: | |
| ISSN: | 2151-464X, 2151-4658, 2151-4658 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Objective
To study the prevalence of fibromyalgia (FM) in the general population according to a 2016 modification of the American College of Rheumatology criteria (FM 2016) and the Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks–American Pain Society pain taxonomy criteria (AAPT), and to compare diagnostic and clinical variables between the criteria sets.
Methods
We studied 2,531 randomly selected subjects from the German general population in 2019. Pain regions from the Michigan Body Map were fitted to the FM 2016 and the AAPT criteria, and criteria symptom items were derived from validated questionnaires assessing somatic and psychological symptom burden and disability. We determined FM criteria prevalence and criteria‐related scales including widespread and multisite pain (MSP) and symptom scales, and measured symptom burden and disability.
Results
According to the FM 2016 criteria, the prevalence of FM was 3.4% (n = 75 subjects; 95% confidence interval [95% CI] 2.7, 4.3) compared with 5.7% (n = 130 subjects; 95% CI 4.8, 6.8) for the AAPT criteria; κ = 0.65. Compared with AAPT‐positive subjects, FM 2016–positive subjects had higher MSP, Widespread Pain Index score, Polysymptomatic Distress Scale scores, Symptom Severity Scores, and psychological symptom burden. Physician‐diagnosed FM was reported by 1.1% of the subjects. Of these, 44.0% met the FM 2016 criteria, and 47.5% met the AAPT criteria.
Conclusion
The prevalence of FM in the German general population is 73% greater using the AAPT criteria than the FM 2016 criteria. The AAPT criteria select individuals with less symptom severity and fewer pain sites. The FM 2016 criteria, but not the AAPT criteria, provide a general severity measure for FM. |
|---|---|
| AbstractList | To study the prevalence of fibromyalgia (FM) in the general population according to a 2016 modification of the American College of Rheumatology criteria (FM 2016) and the Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks-American Pain Society pain taxonomy criteria (AAPT), and to compare diagnostic and clinical variables between the criteria sets.OBJECTIVETo study the prevalence of fibromyalgia (FM) in the general population according to a 2016 modification of the American College of Rheumatology criteria (FM 2016) and the Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks-American Pain Society pain taxonomy criteria (AAPT), and to compare diagnostic and clinical variables between the criteria sets.We studied 2,531 randomly selected subjects from the German general population in 2019. Pain regions from the Michigan Body Map were fitted to the FM 2016 and the AAPT criteria, and criteria symptom items were derived from validated questionnaires assessing somatic and psychological symptom burden and disability. We determined FM criteria prevalence and criteria-related scales including widespread and multisite pain (MSP) and symptom scales, and measured symptom burden and disability.METHODSWe studied 2,531 randomly selected subjects from the German general population in 2019. Pain regions from the Michigan Body Map were fitted to the FM 2016 and the AAPT criteria, and criteria symptom items were derived from validated questionnaires assessing somatic and psychological symptom burden and disability. We determined FM criteria prevalence and criteria-related scales including widespread and multisite pain (MSP) and symptom scales, and measured symptom burden and disability.According to the FM 2016 criteria, the prevalence of FM was 3.4% (n = 75 subjects; 95% confidence interval [95% CI] 2.7, 4.3) compared with 5.7% (n = 130 subjects; 95% CI 4.8, 6.8) for the AAPT criteria; κ = 0.65. Compared with AAPT-positive subjects, FM 2016-positive subjects had higher MSP, Widespread Pain Index score, Polysymptomatic Distress Scale scores, Symptom Severity Scores, and psychological symptom burden. Physician-diagnosed FM was reported by 1.1% of the subjects. Of these, 44.0% met the FM 2016 criteria, and 47.5% met the AAPT criteria.RESULTSAccording to the FM 2016 criteria, the prevalence of FM was 3.4% (n = 75 subjects; 95% confidence interval [95% CI] 2.7, 4.3) compared with 5.7% (n = 130 subjects; 95% CI 4.8, 6.8) for the AAPT criteria; κ = 0.65. Compared with AAPT-positive subjects, FM 2016-positive subjects had higher MSP, Widespread Pain Index score, Polysymptomatic Distress Scale scores, Symptom Severity Scores, and psychological symptom burden. Physician-diagnosed FM was reported by 1.1% of the subjects. Of these, 44.0% met the FM 2016 criteria, and 47.5% met the AAPT criteria.The prevalence of FM in the German general population is 73% greater using the AAPT criteria than the FM 2016 criteria. The AAPT criteria select individuals with less symptom severity and fewer pain sites. The FM 2016 criteria, but not the AAPT criteria, provide a general severity measure for FM.CONCLUSIONThe prevalence of FM in the German general population is 73% greater using the AAPT criteria than the FM 2016 criteria. The AAPT criteria select individuals with less symptom severity and fewer pain sites. The FM 2016 criteria, but not the AAPT criteria, provide a general severity measure for FM. To study the prevalence of fibromyalgia (FM) in the general population according to a 2016 modification of the American College of Rheumatology criteria (FM 2016) and the Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks-American Pain Society pain taxonomy criteria (AAPT), and to compare diagnostic and clinical variables between the criteria sets. We studied 2,531 randomly selected subjects from the German general population in 2019. Pain regions from the Michigan Body Map were fitted to the FM 2016 and the AAPT criteria, and criteria symptom items were derived from validated questionnaires assessing somatic and psychological symptom burden and disability. We determined FM criteria prevalence and criteria-related scales including widespread and multisite pain (MSP) and symptom scales, and measured symptom burden and disability. According to the FM 2016 criteria, the prevalence of FM was 3.4% (n = 75 subjects; 95% confidence interval [95% CI] 2.7, 4.3) compared with 5.7% (n = 130 subjects; 95% CI 4.8, 6.8) for the AAPT criteria; κ = 0.65. Compared with AAPT-positive subjects, FM 2016-positive subjects had higher MSP, Widespread Pain Index score, Polysymptomatic Distress Scale scores, Symptom Severity Scores, and psychological symptom burden. Physician-diagnosed FM was reported by 1.1% of the subjects. Of these, 44.0% met the FM 2016 criteria, and 47.5% met the AAPT criteria. The prevalence of FM in the German general population is 73% greater using the AAPT criteria than the FM 2016 criteria. The AAPT criteria select individuals with less symptom severity and fewer pain sites. The FM 2016 criteria, but not the AAPT criteria, provide a general severity measure for FM. Objective To study the prevalence of fibromyalgia (FM) in the general population according to a 2016 modification of the American College of Rheumatology criteria (FM 2016) and the Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks–American Pain Society pain taxonomy criteria (AAPT), and to compare diagnostic and clinical variables between the criteria sets. Methods We studied 2,531 randomly selected subjects from the German general population in 2019. Pain regions from the Michigan Body Map were fitted to the FM 2016 and the AAPT criteria, and criteria symptom items were derived from validated questionnaires assessing somatic and psychological symptom burden and disability. We determined FM criteria prevalence and criteria‐related scales including widespread and multisite pain (MSP) and symptom scales, and measured symptom burden and disability. Results According to the FM 2016 criteria, the prevalence of FM was 3.4% (n = 75 subjects; 95% confidence interval [95% CI] 2.7, 4.3) compared with 5.7% (n = 130 subjects; 95% CI 4.8, 6.8) for the AAPT criteria; κ = 0.65. Compared with AAPT‐positive subjects, FM 2016–positive subjects had higher MSP, Widespread Pain Index score, Polysymptomatic Distress Scale scores, Symptom Severity Scores, and psychological symptom burden. Physician‐diagnosed FM was reported by 1.1% of the subjects. Of these, 44.0% met the FM 2016 criteria, and 47.5% met the AAPT criteria. Conclusion The prevalence of FM in the German general population is 73% greater using the AAPT criteria than the FM 2016 criteria. The AAPT criteria select individuals with less symptom severity and fewer pain sites. The FM 2016 criteria, but not the AAPT criteria, provide a general severity measure for FM. ObjectiveTo study the prevalence of fibromyalgia (FM) in the general population according to a 2016 modification of the American College of Rheumatology criteria (FM 2016) and the Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks–American Pain Society pain taxonomy criteria (AAPT), and to compare diagnostic and clinical variables between the criteria sets.MethodsWe studied 2,531 randomly selected subjects from the German general population in 2019. Pain regions from the Michigan Body Map were fitted to the FM 2016 and the AAPT criteria, and criteria symptom items were derived from validated questionnaires assessing somatic and psychological symptom burden and disability. We determined FM criteria prevalence and criteria‐related scales including widespread and multisite pain (MSP) and symptom scales, and measured symptom burden and disability.ResultsAccording to the FM 2016 criteria, the prevalence of FM was 3.4% (n = 75 subjects; 95% confidence interval [95% CI] 2.7, 4.3) compared with 5.7% (n = 130 subjects; 95% CI 4.8, 6.8) for the AAPT criteria; κ = 0.65. Compared with AAPT‐positive subjects, FM 2016–positive subjects had higher MSP, Widespread Pain Index score, Polysymptomatic Distress Scale scores, Symptom Severity Scores, and psychological symptom burden. Physician‐diagnosed FM was reported by 1.1% of the subjects. Of these, 44.0% met the FM 2016 criteria, and 47.5% met the AAPT criteria.ConclusionThe prevalence of FM in the German general population is 73% greater using the AAPT criteria than the FM 2016 criteria. The AAPT criteria select individuals with less symptom severity and fewer pain sites. The FM 2016 criteria, but not the AAPT criteria, provide a general severity measure for FM. |
| Author | Ablin, Jacob Häuser, Winfried Brähler, Elmar Wolfe, Frederick |
| Author_xml | – sequence: 1 givenname: Winfried surname: Häuser fullname: Häuser, Winfried organization: Klinikum Saarbrücken, Saarbrücken, Germany, and Technische Universität München – sequence: 2 givenname: Elmar surname: Brähler fullname: Brähler, Elmar organization: University Medical Center of the Johannes Gutenberg University Mainz – sequence: 3 givenname: Jacob surname: Ablin fullname: Ablin, Jacob organization: Tel Aviv University – sequence: 4 givenname: Frederick orcidid: 0000-0002-2801-6413 surname: Wolfe fullname: Wolfe, Frederick email: fwolfe@arthritis-research.org organization: National Data Bank for Rheumatic Diseases |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32248629$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9ks1u1DAQgCNUREvpgRdAlriA1G3jn2ST42pFoVKhVdkDt2hiT7Yujr21nZa98Q68Ia_BBe8PK1QJfLDH429-PDPPsz3rLGbZS5qf0DxnpyD9CRMsZ0-yA0YLOhJlUe3tZPFlPzsK4TZPi7Oq4vWzbJ8zJqqS1QfZr49O6U6jIiynJZn06LUES6bOGJwjcR25vsGhh-iMmy_JmW6965dg5hrI1OuYeDgm8QbJxCYtBi2Pk4ghqeJKBqvIRCkto3bJr9E2BTBkluxWO9hgYPUUyLm17n4rXy4WzsfB6qgxrH18wvjg_Nfw8_uPXZZXoC357KTGuNxcZvDN2ZTgJu4qrSuP92DQyvVn_s7_Rfa0AxPwaHseZrOzd7Pph9HF5fvz6eRiJHnB2aildYE1L8c57UDSFoGqtpVKVEIAhbqGvBsD5Z3gIKoWoJUVU6ooijFDxflh9mbjduHd3ZAK0_Q6SDQGLLohNIxXpeBFTcuEvn6E3rrBp7omqmCirFLTRKJebamh7VE1C6978MvmT1cT8HYDSO9C8NjtEJo3q6Fp0tA066FJ7OkjVuq4bkL0oM3_LB60weW_XTeT6fXG4jf0Gdfp |
| CitedBy_id | crossref_primary_10_1093_rheumatology_keaf148 crossref_primary_10_1080_1028415X_2025_2518210 crossref_primary_10_1002_acr_24198 crossref_primary_10_1097_j_pain_0000000000002905 crossref_primary_10_1186_s12874_023_01926_4 crossref_primary_10_1038_s41598_024_54365_6 crossref_primary_10_1007_s00393_024_01603_x crossref_primary_10_1093_jpepsy_jsaf060 crossref_primary_10_1111_imj_15430 crossref_primary_10_1002_art_42691 crossref_primary_10_1097_MD_0000000000041706 crossref_primary_10_1016_j_ejogrb_2024_10_050 crossref_primary_10_1007_s00406_022_01422_8 crossref_primary_10_1109_ACCESS_2025_3539196 crossref_primary_10_3390_ijerph19084613 crossref_primary_10_1002_acr2_11476 crossref_primary_10_1371_journal_pone_0254862 crossref_primary_10_1002_ejp_4771 crossref_primary_10_1007_s40122_024_00646_x crossref_primary_10_7759_cureus_20010 crossref_primary_10_7759_cureus_20351 crossref_primary_10_1001_jamanetworkopen_2024_46603 crossref_primary_10_2147_JPR_S498935 crossref_primary_10_1080_09638288_2022_2127931 crossref_primary_10_1097_j_pain_0000000000003562 |
| Cites_doi | 10.1016/0049-0172(81)90096-2 10.1093/rheumatology/keq155 10.1016/j.jpsychores.2015.03.006 10.1002/art.1780330203 10.1002/art.10993 10.3899/jrheum.141519 10.1097/j.pain.0000000000000417 10.1159/000484413 10.1002/acr.20140 10.1097/00006842-200203000-00008 10.1016/S0895-4356(98)00109-7 10.1038/nrrheum.2013.96 10.1136/ard.56.4.268 10.1002/acr.23731 10.1007/s11916-013-0356-5 10.1001/jamainternmed.2013.12179 10.1002/acr.21931 10.1002/acr2.1006 10.1007/s00296-017-3725-2 10.1053/berh.1999.0029 10.1016/j.semarthrit.2016.08.012 10.1016/j.jpain.2018.10.008 10.1016/S1521-6942(03)00036-6 10.1097/j.pain.0000000000000506 10.3899/jrheum.110026 10.1016/j.berh.2007.03.003 10.1016/j.clinph.2018.09.030 10.1016/S0022-3999(01)00224-0 10.1097/j.pain.0000000000001390 10.1055/s-2003-41645 10.1371/journal.pone.0203755 10.1097/j.pain.0000000000000314 10.3899/jrheum.100594 10.1007/s00132-012-1901-3 10.11613/BM.2012.031 10.1371/journal.pone.0157235 10.1016/S0033-3182(09)70864-3 |
| ContentType | Journal Article |
| Copyright | 2020, American College of Rheumatology 2020, American College of Rheumatology. 2021 American College of Rheumatology |
| Copyright_xml | – notice: 2020, American College of Rheumatology – notice: 2020, American College of Rheumatology. – notice: 2021 American College of Rheumatology |
| DBID | AAYXX CITATION NPM 7QP NAPCQ 7X8 |
| DOI | 10.1002/acr.24202 |
| DatabaseName | CrossRef PubMed Calcium & Calcified Tissue Abstracts Nursing & Allied Health Premium MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed Nursing & Allied Health Premium Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed Nursing & Allied Health Premium |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2151-4658 |
| EndPage | 625 |
| ExternalDocumentID | 32248629 10_1002_acr_24202 ACR24202 |
| Genre | article Journal Article |
| GroupedDBID | .3N .GA .Y3 0R~ 10A 1OC 24P 31~ 33P 4.4 50Z 51W 51X 52N 52O 52P 52R 52S 52T 52W 52X 53G 5VS 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCUV ABIJN ABQWH ABXGK ACAHQ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADMGS ADOZA ADXAS ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUYR AFBPY AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AIACR AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BFHJK BHBCM BMXJE BRXPI BY8 D-6 D-7 D-E D-F DCZOG DR2 DRFUL DRMAN DRSTM EBS EJD EMOBN F00 F01 F04 F5P FUBAC G-S GODZA H.X HF~ HGLYW HZ~ J0M J5H KBYEO LATKE LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N04 N05 NF~ O66 O9- P2P P2W P2X P2Z P4B P4D Q.N QB0 ROL SUPJJ TEORI UB1 V9Y W8V W99 WBKPD WHWMO WIK WOHZO WQJ WVDHM WXI WXSBR XG1 ZZTAW ~WT AAMMB AAYXX ABJNI AEFGJ AEYWJ AGHNM AGXDD AGYGG AIDQK AIDYY CITATION O8X OVD NPM 7QP NAPCQ 7X8 |
| ID | FETCH-LOGICAL-c3532-b195e936701fac1bea1dbbcd4844a1a99a0f7a13f43a48baabc82dd55572ed33 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 36 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000649040200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2151-464X 2151-4658 |
| IngestDate | Fri Jul 11 07:09:57 EDT 2025 Fri Jul 25 02:22:55 EDT 2025 Thu Apr 03 07:02:12 EDT 2025 Tue Nov 18 22:40:28 EST 2025 Sat Nov 29 07:22:54 EST 2025 Wed Jan 22 16:29:26 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| License | 2020, American College of Rheumatology. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3532-b195e936701fac1bea1dbbcd4844a1a99a0f7a13f43a48baabc82dd55572ed33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| ORCID | 0000-0002-2801-6413 |
| PMID | 32248629 |
| PQID | 2524688624 |
| PQPubID | 2045195 |
| PageCount | 4 |
| ParticipantIDs | proquest_miscellaneous_2386435916 proquest_journals_2524688624 pubmed_primary_32248629 crossref_primary_10_1002_acr_24202 crossref_citationtrail_10_1002_acr_24202 wiley_primary_10_1002_acr_24202_ACR24202 |
| PublicationCentury | 2000 |
| PublicationDate | May 2021 2021-05-00 2021-May 20210501 |
| PublicationDateYYYYMMDD | 2021-05-01 |
| PublicationDate_xml | – month: 05 year: 2021 text: May 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Atlanta |
| PublicationTitle | Arthritis care & research (2010) |
| PublicationTitleAlternate | Arthritis Care Res (Hoboken) |
| PublicationYear | 2021 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2015; 78 1990; 33 2019; 71 2013; 65 2019; 1 2003; 17 2011; 38 2018; 87 2019; 160 2010; 62 2013; 9 2016; 11 2013; 17 2019; 20 2017; 37 2002; 64 2009; 50 2015; 42 2017; 35 2011; 50 1997; 56 2016; 157 1999; 13 2018 2003; 49 2014 1998; 51 2019; 130 2007; 21 2012; 22 2003; 42 2001; 51 2016; 46 2012; 41 1981; 11 2018; 13 e_1_2_6_32_1 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_30_1 Stata (e_1_2_6_19_1) 2018 e_1_2_6_13_1 e_1_2_6_36_1 e_1_2_6_14_1 e_1_2_6_35_1 e_1_2_6_11_1 e_1_2_6_34_1 e_1_2_6_12_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_39_1 e_1_2_6_15_1 e_1_2_6_38_1 e_1_2_6_16_1 e_1_2_6_37_1 e_1_2_6_21_1 e_1_2_6_20_1 e_1_2_6_40_1 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 Wolfe F (e_1_2_6_33_1) 2017; 35 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_29_1 e_1_2_6_28_1 e_1_2_6_27_1 e_1_2_6_26_1 |
| References_xml | – volume: 49 start-page: 156 year: 2003 end-page: 63 article-title: The Self‐Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research publication-title: Arthritis Rheum – volume: 11 start-page: 151 year: 1981 end-page: 71 article-title: Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls publication-title: Semin Arthritis Rheum – volume: 17 start-page: 356 year: 2013 article-title: Worldwide epidemiology of fibromyalgia publication-title: Curr Pain Headache Rep – volume: 157 start-page: 541 year: 2016 end-page: 3 article-title: Chronic widespread pain: the need for a standard definition publication-title: Pain – volume: 62 start-page: 600 year: 2010 end-page: 10 article-title: The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity publication-title: Arthritis Care Res (Hoboken) – volume: 51 start-page: 1171 year: 1998 end-page: 8 article-title: Cross‐validation of item selection and scoring for the SF‐12 Health Survey in nine countries: results from the IQOLA Project publication-title: J Clin Epidemiol – volume: 9 start-page: 751 year: 2013 article-title: Culture, science and the changing nature of fibromyalgia publication-title: Nat Rev Rheumatol – volume: 46 start-page: 319 year: 2016 end-page: 29 article-title: 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria publication-title: Semin Arthritis Rheum – volume: 51 start-page: 549 year: 2001 end-page: 57 article-title: How many functional somatic syndromes? publication-title: J Psychosom Res – volume: 130 start-page: 12 year: 2019 end-page: 9 article-title: Fibromyalgia: increased reactivity of the muscle membrane and a role of central regulation publication-title: Clin Neurophysiol – volume: 17 start-page: 593 year: 2003 end-page: 609 article-title: Evoked pain measures in fibromyalgia publication-title: Best Pract Res Clin Rheumatol – volume: 11 year: 2016 article-title: Three‐quarters of individuals in the US population reporting a clinical diagnosis of fibromyalgia do not satisfy fibromyalgia criteria: the 2012 National Health Interview Survey publication-title: PLoS One – volume: 41 start-page: 303 year: 2012 end-page: 10 article-title: Comorbidity from the patient perspective‐does it work? Validity of a questionnaire on self‐estimation of comorbidity (SCQ‐D) publication-title: Der Orthopade – volume: 65 start-page: 777 year: 2013 end-page: 85 article-title: Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population publication-title: Arthritis Care Res (Hoboken) – volume: 42 start-page: 218 year: 2003 end-page: 25 article-title: Der SF‐36 in der Rehabilitationswissenschaftlichen Forschung‐Ergebnisse aus dem Norddeutschen Verbund für Rehabilitationsforschung (NVRF) im Förderschwerpunkt Rehabilitationswissenschaften publication-title: Die Rehabilitation – year: 2018 – volume: 50 start-page: 16 year: 2011 end-page: 24 article-title: The National Data Bank for rheumatic diseases: a multi‐registry rheumatic disease data bank publication-title: Rheumatology (Oxford) – volume: 56 start-page: 268 year: 1997 end-page: 71 article-title: The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic publication-title: Ann Rheum Dis – volume: 71 start-page: 343 year: 2019 end-page: 51 article-title: Diagnosis of fibromyalgia: disagreement between fibromyalgia criteria and clinician‐based fibromyalgia diagnosis in a university clinic publication-title: Arthritis Care Res (Hoboken) – volume: 38 start-page: 2238 year: 2011 end-page: 46 article-title: The longitudinal outcome of fibromyalgia: a study of 1555 patients publication-title: J Rheumatol – volume: 13 year: 2018 article-title: Fibromyalgia diagnosis and biased assessment: sex, prevalence and bias publication-title: PLoS One – volume: 21 start-page: 403 year: 2007 end-page: 25 article-title: Epidemiology of chronic musculoskeletal pain publication-title: Best Pract Res Clin Rheumatol – volume: 35 start-page: 3 issue: Suppl 105 year: 2017 end-page: 5 article-title: Criteria for fibromyalgia? What is fibromyalgia? Limitations to current concepts about fibromyalgia and fibromyalgia criteria [editorial] publication-title: Clin Exp Rheumatol – start-page: 399 year: 2014 end-page: 407 article-title: The Somatic Symptom Scale–8 (SSS‐8): a brief measure of somatic symptom burden publication-title: JAMA Intern Med – volume: 160 start-page: 28 year: 2019 end-page: 37 article-title: The IASP classification of chronic pain for ICD‐11: chronic primary pain publication-title: Pain – volume: 13 start-page: 403 year: 1999 end-page: 14 article-title: Generalized pain, fibromyalgia and regional pain: an epidemiological view publication-title: Baillieres Best Pract Res Clin Rheumatol – volume: 1 start-page: 43 year: 2019 end-page: 51 article-title: The problematic nature of fibromyalgia diagnosis in the community publication-title: ACR Open Rheumatol – volume: 37 start-page: 1527 year: 2017 end-page: 39 article-title: Prevalence of fibromyalgia in general population and patients, a systematic review and meta‐analysis publication-title: Rheumatol Int – volume: 33 start-page: 160 year: 1990 end-page: 72 article-title: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee publication-title: Arthritis Rheum – volume: 20 start-page: 611 year: 2019 end-page: 28 article-title: AAPT diagnostic criteria for fibromyalgia publication-title: J Pain – volume: 87 start-page: 12 year: 2018 end-page: 31 article-title: Management of functional somatic syndromes and bodily distress publication-title: Psychother Psychosom – volume: 157 start-page: 55 year: 2016 article-title: A systematic review and meta‐analysis of the prevalence of chronic widespread pain in the general population publication-title: Pain – volume: 78 start-page: 536 year: 2015 end-page: 45 article-title: A new questionnaire to identify bodily distress in primary care: the ‘BDS checklist’ publication-title: J Psychosom Res – volume: 22 start-page: 276 year: 2012 end-page: 82 article-title: Interrater reliability: the kappa statistic publication-title: Biochem Med (Zagreb) – volume: 42 start-page: 1494 year: 2015 end-page: 501 article-title: The use of polysymptomatic distress categories in the evaluation of fibromyalgia (FM) and FM severity publication-title: J Rheumatol – volume: 38 start-page: 1113 year: 2011 end-page: 22 article-title: Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia publication-title: J Rheumatol – volume: 64 start-page: 258 year: 2002 end-page: 66 article-title: The PHQ‐15: validity of a new measure for evaluating the severity of somatic symptoms publication-title: Psychosom Med – volume: 50 start-page: 613 year: 2009 end-page: 21 article-title: An ultra‐brief screening scale for anxiety and depression: the PHQ–4 publication-title: Psychosomatics – volume: 157 start-page: 1205 year: 2016 article-title: Preliminary validation of the Michigan Body Map (MBM) publication-title: Pain – ident: e_1_2_6_24_1 doi: 10.1016/0049-0172(81)90096-2 – volume: 35 start-page: 3 issue: 105 year: 2017 ident: e_1_2_6_33_1 article-title: Criteria for fibromyalgia? What is fibromyalgia? Limitations to current concepts about fibromyalgia and fibromyalgia criteria [editorial] publication-title: Clin Exp Rheumatol – volume-title: Stata statistical software: release 15.0 year: 2018 ident: e_1_2_6_19_1 – ident: e_1_2_6_18_1 doi: 10.1093/rheumatology/keq155 – ident: e_1_2_6_17_1 doi: 10.1016/j.jpsychores.2015.03.006 – ident: e_1_2_6_2_1 doi: 10.1002/art.1780330203 – ident: e_1_2_6_15_1 doi: 10.1002/art.10993 – ident: e_1_2_6_38_1 doi: 10.3899/jrheum.141519 – ident: e_1_2_6_3_1 doi: 10.1097/j.pain.0000000000000417 – ident: e_1_2_6_29_1 doi: 10.1159/000484413 – ident: e_1_2_6_4_1 doi: 10.1002/acr.20140 – ident: e_1_2_6_10_1 doi: 10.1097/00006842-200203000-00008 – ident: e_1_2_6_13_1 doi: 10.1016/S0895-4356(98)00109-7 – ident: e_1_2_6_22_1 doi: 10.1038/nrrheum.2013.96 – ident: e_1_2_6_26_1 doi: 10.1136/ard.56.4.268 – ident: e_1_2_6_35_1 doi: 10.1002/acr.23731 – ident: e_1_2_6_39_1 doi: 10.1007/s11916-013-0356-5 – ident: e_1_2_6_11_1 doi: 10.1001/jamainternmed.2013.12179 – ident: e_1_2_6_21_1 doi: 10.1002/acr.21931 – ident: e_1_2_6_34_1 doi: 10.1002/acr2.1006 – ident: e_1_2_6_8_1 doi: 10.1007/s00296-017-3725-2 – ident: e_1_2_6_32_1 doi: 10.1053/berh.1999.0029 – ident: e_1_2_6_6_1 doi: 10.1016/j.semarthrit.2016.08.012 – ident: e_1_2_6_7_1 doi: 10.1016/j.jpain.2018.10.008 – ident: e_1_2_6_25_1 doi: 10.1016/S1521-6942(03)00036-6 – ident: e_1_2_6_9_1 doi: 10.1097/j.pain.0000000000000506 – ident: e_1_2_6_27_1 doi: 10.3899/jrheum.110026 – ident: e_1_2_6_31_1 doi: 10.1016/j.berh.2007.03.003 – ident: e_1_2_6_23_1 doi: 10.1016/j.clinph.2018.09.030 – ident: e_1_2_6_28_1 doi: 10.1016/S0022-3999(01)00224-0 – ident: e_1_2_6_30_1 doi: 10.1097/j.pain.0000000000001390 – ident: e_1_2_6_14_1 doi: 10.1055/s-2003-41645 – ident: e_1_2_6_37_1 doi: 10.1371/journal.pone.0203755 – ident: e_1_2_6_40_1 doi: 10.1097/j.pain.0000000000000314 – ident: e_1_2_6_5_1 doi: 10.3899/jrheum.100594 – ident: e_1_2_6_16_1 doi: 10.1007/s00132-012-1901-3 – ident: e_1_2_6_20_1 doi: 10.11613/BM.2012.031 – ident: e_1_2_6_36_1 doi: 10.1371/journal.pone.0157235 – ident: e_1_2_6_12_1 doi: 10.1016/S0033-3182(09)70864-3 |
| SSID | ssj0000328839 |
| Score | 2.4947405 |
| Snippet | Objective
To study the prevalence of fibromyalgia (FM) in the general population according to a 2016 modification of the American College of Rheumatology... To study the prevalence of fibromyalgia (FM) in the general population according to a 2016 modification of the American College of Rheumatology criteria (FM... ObjectiveTo study the prevalence of fibromyalgia (FM) in the general population according to a 2016 modification of the American College of Rheumatology... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 617 |
| SubjectTerms | Addictions Analgesics Clinical trials Fibromyalgia Pain Rheumatology Taxonomy |
| Title | Modified 2016 American College of Rheumatology Fibromyalgia Criteria, the Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks–American Pain Society Pain Taxonomy, and the Prevalence of Fibromyalgia |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Facr.24202 https://www.ncbi.nlm.nih.gov/pubmed/32248629 https://www.proquest.com/docview/2524688624 https://www.proquest.com/docview/2386435916 |
| Volume | 73 |
| WOSCitedRecordID | wos000649040200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 2151-4658 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000328839 issn: 2151-464X databaseCode: DRFUL dateStart: 20100101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELbKFiEu5Z8ulMogDhw27cZxEkecVoUVSO1SrRZpb9HEdtpIS1JtughuvANvyGtwYcb5gQqQkLglih2P5c-esT3zDWPPfaXwg7BeHoXWkwKUBz5dFwYxBDEi2mgXKHwcz2ZquUxOt9jLLham4YfoD9xoZrj1miY4ZPXhT9JQ0OsD1C9EJLktELdywLZfzafvj_sjFqKKUy6XGOk1T0Zy2XELjcVhX_-qRvrNzLxqtTq1M731XwLfZjuttcknDTzusC1b3mU3Ttr79Hvs-0llihytUI4aOuLd9Q1vjxN4lfP5ud2gVetO3_kUBag-fIbVWQGcsiQQfkccjUhO7CZnFsd8hI_Ys3OKjhxxKA2fGFO48AnespCu-IJwz52ibJ3x-Ns-P2vN313QtmBTOrpX949Z465ef_vytZfyFIqSt26nzcsCPrkgjaZdEosoqsAFVlFnfpX_PltMXy-O3nhtOghPB2EgvMxPQpsQ4Zyfg_YzC77JMm2kkhJ8SBIY5zH4QS4DkCoDyLQSxoRhGAtrguABG5RVaXcZj4SOTaLGEeSZxIpJrHFnRTuzXEMG8ZC96BCR6pYqnTJ2rNKG5FmkOJapG8she9YXvWj4Qf5UaK-DVdouEXUqQiEjRfE5Q_a0_4yTm25soLTVBssECi3GEE34IXvYwLFvBVdiibUTFNah7u_Np5OjuXt49O9FH7Obgrx3nGvnHhtcrjf2CbuuP14W9XqfXYuXar-dbz8AdjIx0g |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELZWXQRceD8KCxjEgUPDNo6TOBKXaqHaFW1ZVUHqLZrYzm6lkqzaLYIb_4F_yN_gwozzgBUgIXFLFbueyJ894_HMN4w995XCF8J6RRRaTwpQHvh0XRjEEMSIaKNdovAkns3UYpEc77BXbS5MzQ_ROdxoZbj9mhY4OaT3f7KGgl6_RAVDTJK7EmEU9tju6_n4_aTzsRBXnHLFxEixeTKSi5ZcaCj2u_4XVdJvduZFs9XpnfH1_5P4BrvW2Jt8VAPkJtux5S12edrcqN9m36eVWRZoh3LU0RFvL3B441DgVcHnp3aLdq3zv_MxSlB9-AyrkyVwqpNACB5wNCM58ZucWJz1AT7ip51SfuSAQ2n4yJilS6DgDQ_piqeEfO5UZROOx4-6Cq0b_u6MDgbb0hG-uv-Y1QHrm29fvnZSHsOy5E3gaf0jhU8uTaMel8QikipwqVX0Mb_Kf4el4zfpwaHXFITwdBAGwsv9JLQJUc75BWg_t-CbPNdGKinBhySBYRGDHxQyAKlygFwrYUwYhrGwJgjusl5ZlfY-45HQsUnUMIIil9gxiTWerehsVmjIIe6zFy0kMt2QpVPNjlVW0zyLDOcyc3PZZ8-6pmc1Q8ifGu21uMqaTWKTiVDISFGGTp897V7j8qY7GyhttcU2gUKbMUQjvs_u1XjsRsG9WGLvBIV1sPv78NnoYO4eHvx70yfsymE6nWSTo9nbh-yqoFgeF-i5x3rn6619xC7pj-fLzfpxs-x-AHFuNNo |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELZWu2jFhfejsIBBHDg0bOM4iSNxqXapWNEtVVWk3qKJ7exGKknVbhHc-A_8Q_4GF2acB6wACYmbI9vxWJ7xjO2Zbxh77iuFFcJ6eRRaTwpQHvj0XBjEEMTI0Ua7QOFxPJmoxSKZ7rBXbSxMjQ_RXbiRZLj9mgTcrkx--BM1FPT6JSoYQpLck2ESoVjuHc9G78fdHQthxSmXTIwUmycjuWjBhQbisOt_WSX9ZmdeNlud3hld_z-Kb7Brjb3JhzWD3GQ7trzF9k-bF_Xb7PtpZYoc7VCOOjri7QMOby4UeJXz2bndol3r7t_5CCmoPnyG5VkBnPIkEAf3OZqRnPBNziyueh-LOLVzio_scygNHxpTuAAK3uCQLvmcOJ87Vdm44_GTLkPrhr9b0cFgWzrAV_ePSe2wvvn25WtH5RSKkjeOp_XHHD65MI16XCKLQKrAhVbRZH6l_w6bj17Pj954TUIITwdhILzMT0KbEOScn4P2Mwu-yTJtpJISfEgSGOQx-EEuA5AqA8i0EsaEYRgLa4LgLtstq9LeZzwSOjaJGkSQZxI7JrHGsxWdzXINGcQ99qJliVQ3YOmUs2OZ1jDPIsW1TN1a9tizrumqRgj5U6ODlq_SZpPYpCIUMlIUodNjT7tqFG96s4HSVltsEyi0GUM04nvsXs2P3Si4F0vsnSCxju3-Pnw6PJq5woN_b_qE7U-PR-n4ZPL2IbsqyJXH-XkesN2L9dY-Ylf0x4tis37cSN0PsT00VQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Modified+2016+American+College+of+Rheumatology+Fibromyalgia+Criteria%2C+the+Analgesic%2C+Anesthetic%2C+and+Addiction+Clinical+Trial+Translations+Innovations+Opportunities+and+Networks-American+Pain+Society+Pain+Taxonomy%2C+and+the+Prevalence+of+Fibromyalgia&rft.jtitle=Arthritis+care+%26+research+%282010%29&rft.au=H%C3%A4user%2C+Winfried&rft.au=Br%C3%A4hler%2C+Elmar&rft.au=Ablin%2C+Jacob&rft.au=Wolfe%2C+Frederick&rft.date=2021-05-01&rft.eissn=2151-4658&rft.volume=73&rft.issue=5&rft.spage=617&rft_id=info:doi/10.1002%2Facr.24202&rft_id=info%3Apmid%2F32248629&rft.externalDocID=32248629 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2151-464X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2151-464X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2151-464X&client=summon |